NEU 2.60% $15.34 neuren pharmaceuticals limited

autism, retts and nnz-2566, page-2

  1. 35,748 Posts.
    lightbulb Created with Sketch. 554
    You only have to look at the Board for Autism Speaks that says that $38.7M push towards finidng drugs to treat Autism is only the tip of the iceberg - while no doubt Roche is what first appears the headline being in the top 5 big pharma globally the board of Autism Speaks is linked to probably the biggest source off cash anywhere with many high profile appointments to the board mainly as a result of their children having Autism, it goes to show the power out there to reach a soultion. If the science is there I think the money will be right behind it.

    Autism Speaks Board

    Curtis Arledge
    CEO - BNY Mellon (with $27 Trillion in assets under management)

    Adrian M. Jones
    Managing Director - Goldman Sachs

    T. Michael Glenn
    Exec. Vice President - FedEx Corporation

    Bernie Marcus
    CoFounder - The Home Depot






 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$15.34
Change
-0.410(2.60%)
Mkt cap ! $1.960B
Open High Low Value Volume
$15.88 $15.93 $15.34 $6.463M 415.6K

Buyers (Bids)

No. Vol. Price($)
3 6044 $15.32
 

Sellers (Offers)

Price($) Vol. No.
$15.57 1411 2
View Market Depth
Last trade - 16.10pm 28/08/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.